STOCK TITAN

Carisma Therapeutics to Present at Upcoming Conferences

Rhea-AI Impact
(Low)
Rhea-AI Sentiment
(Neutral)
Tags
conferences
Rhea-AI Summary
Carisma Therapeutics Inc. (Nasdaq: CARM) announces participation in upcoming healthcare conferences with presentations by President and CEO Steven Kelly. Webcasts will be available for investors to view.
Positive
  • None.
Negative
  • None.

PHILADELPHIA, April 3, 2024 /PRNewswire/ -- Carisma Therapeutics Inc. (Nasdaq: CARM) ("Carisma" or the "Company"), a clinical-stage biopharmaceutical company focused on discovering and developing innovative immunotherapies, today announced that it will present at the following upcoming conferences:

Needham 23rd Annual Virtual Healthcare Conference

  • Steven Kelly, President and Chief Executive Officer, will give a corporate presentation.
  • Wednesday, April 10 at 3:45 PM ET
  • Virtual

Chardan 8th Annual Genetic Medicines & Cell Therapy Manufacturing Summit

  • Steven Kelly, President and Chief Executive Officer, will give a corporate presentation.
  • Monday, April 29 at 2:00 PM ET
  • Virtual

Live webcasts will be available on the Company's Investor Events webpage. A replay of the webcasts, when available, will be archived for a limited time following each event.

About Carisma 

Carisma Therapeutics Inc. is a clinical-stage biopharmaceutical company focused on utilizing our proprietary macrophage and monocyte cell engineering platform to develop transformative immunotherapies to treat cancer and other serious diseases. We have created a comprehensive, differentiated proprietary cell therapy platform focused on engineered macrophages and monocytes, cells that play a crucial role in both the innate and adaptive immune response. Carisma is headquartered in Philadelphia, PA. For more information, please visit www.carismatx.com.

Investors:
Shveta Dighe
Head of Investor Relations
investors@carismatx.com

Media Contact:
Julia Stern
(763) 350-5223
jstern@realchemistry.com

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/carisma-therapeutics-to-present-at-upcoming-conferences-302106448.html

SOURCE Carisma Therapeutics Inc.

Carisma Therapeutics will present at the Needham 23rd Annual Virtual Healthcare Conference on Wednesday, April 10 at 3:45 PM ET.

President and Chief Executive Officer Steven Kelly will give the corporate presentation at the Chardan 8th Annual Genetic Medicines & Cell Therapy Manufacturing Summit on Monday, April 29 at 2:00 PM ET.

Investors can watch the webcasts of the presentations on Carisma Therapeutics' Investor Events webpage.

Yes, a replay of the webcasts will be archived for a time following each event.
Carisma Therapeutics Inc

NASDAQ:CARM

CARM Rankings

CARM Latest News

CARM Stock Data

Pharmaceutical Preparation Manufacturing
Manufacturing
Link
US
Cambridge

About CARM

eleven biotherapeutics is focused on translating breakthrough discoveries from science and medicine to engineer and develop innovative protein-based therapeutics to improve human health and treat disease. eleven biotherapeutics' scientists are engineering protein-based drugs using newly available structural information and the company’s unique molecular understanding of clinical effects to create the next generation of protein-based medicines to treat important diseases with unmet needs, such as inflammatory conditions and coagulation disorders.